Newsletter
Industry Watch
In the second week of August, we bring you news of an existing arthritis drug could help a third of diabetes patients, delaying the progress of the…
All Results
Newsletter
Fact Sheet
The Center for Immuno-oncology, Cellular, and Gene Therapy Fact Sheet
The Center for Immuno-oncology, Cellular, and Gene Therapy leverages our comprehensive experience and cross-functional experts to build…
Newsletter
Industry Watch
In the second week of July, we bring you news of developments in HIV research, as well as updates on immunotherapies, Alzheimer’s disease,…
Page
The Center for Immuno-oncology, Cellular, and Gene Therapy
We provide end-to-end support for your complex, fast-paced immunotherapy studies.
Blog
Ask the Experts: How Does Immunization Protect Us?
PRA experts from the Center for Vaccine Research—Darin Seehafer, Director of Therapeutic Expertise, and Lynlee Burton, Head, Center for Vaccine…
Blog
Ask the Experts: How Do We Control and Prevent Malaria?
In advance of World Malaria Day, we spoke with Darin Seehafer, Director of Therapeutic Expertise, from PRA’s Center for Vaccine Research, and the…
Case Study
PRA Delivers Study Start-up Success
PRA was awarded a rheumatoid arthritis study contract based on our strategy for achieving first-patient-in (FPI) by the end of the calendar year.…
Case Study
Persistence Leads To High Enrollment
A Phase IV, randomized, single-blind, placebo-controlled, multi-center study to evaluate the immunogenicity of pneumococcal and influenza vaccines in…
Case Study
Targeting Patients In A Complex Phase II Rheumatoid Arthritis Study
Targeting Patients In A Complex Phase IIa Rheumatoid Arthritis Study.
Fact Sheet
Central Review Services
PRA's Central Review Services team, unique in the CRO industry, offers lupus-specific expertise in efficacy endpoint data correlation, standardized…